
Keywords: Choline; Methyl; Prostate cancer; Sphingomyelin; Statin; BPH; benign prostatic hyperplasia; DMG; dimethylglycine; LDL; low density lipoproteins; Lyso-PtdCho; lysophosphatidylcholine; PCa; prostate cancer; PtdCho; phosphatidylcholine; PtdEth; phosphatidyle